Chiara Liberati

Biography

Chiara was appointed Director of Discovery Research at Axxam in October 2017.  She is responsible for managing Axxam’s discovery projects also including fund raising for the generation of NewCos. Prior to that, Chiara was Head of Discovery Biology, coordinating a wide range of proprietary multidisciplinary programs in the therapeutic areas of Inflammation, Autoimmune Diseases, and CNS, in collaboration with pharmaceutical companies and renowned international research institutes. Chiara was actively involved in Axxam's most recent asset transfer into a NewCo focused on new therapeutics to treat hearing loss. Before Axxam, she worked at Bayer Pharma Italia and Biosearch Italia SpA. Following the BS in Molecular and Cellular Biology, Chiara achieved a Master in Human Molecular Genetics at University of Milan by working on human globin genes regulation.  She is author of about 20 publications and patents. Chiara was appointed Director of Discovery Research at Axxam in October 2017.  She is responsible for managing Axxam’s discovery projects also including fund raising for the generation of NewCos. Prior to that, Chiara was Head of Discovery Biology, coordinating a wide range of proprietary multidisciplinary programs in the therapeutic areas of Inflammation, Autoimmune Diseases, and CNS, in collaboration with pharmaceutical companies and renowned international research institutes. Chiara was actively involved in Axxam's most recent asset transfer into a NewCo focused on new therapeutics to treat hearing loss. Before Axxam, she worked at Bayer Pharma Italia and Biosearch Italia SpA. Following the BS in Molecular and Cellular Biology, Chiara achieved a Master in Human Molecular Genetics at University of Milan by working on human globin genes regulation.  She is author of about 20 publications and patents.

Research Interest

Biotechnology, Molecular Biology and Biochemistry